Showing results (1131-1140 of 1,378) with videos related to

Sort By:
Pageof 138
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1989
In vitro and in vivo characteristics of [iodine-125] 3-(R)-quinuclidinyl (S)-4-iodobenzilateR E Gibson, T A Schneidau, V I Cohen, et al.
Emerging Infectious Diseases|October 20, 2017
Mycobacterium lepromatosis Lepromatous Leprosy in US Citizen Who Traveled to Disease-Endemic AreasAbinash Virk, Bobbi Pritt, Robin Patel, et al.
Journal of Pharmaceutical Sciences|April 1, 1992
Synthesis and receptor affinities of new 3-quinuclidinyl alpha-heteroaryl-alpha-aryl-alpha-hydroxyacetatesV I Cohen, R E Gibson, L H Fan, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|February 24, 2016
Towards high-accuracy primary spectral radiometry from 400 K to 1300 KH W Yoon, V B Khromchenko, G P Eppeldauer, et al.
British Journal of Haematology|July 26, 2002
Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XIJudith M Chessells, Georgina Harrison, Susan M Richards, et al.
Canadian Medical Association Journal|March 18, 1978
The impact of a new geriatric program in a hospital for the chronically illJ E Schuman, E J Beattie, D A Steed, et al.
Emergency Medicine Journal : EMJ|July 16, 2013
"Can you send an ambulance please?": a comparison of callers' requests for emergency medical dispatch in non-stroke and stroke callsMichael J Leathley, Stephanie P Jones, Josephine M E Gibson, et al.
Conservation Physiology|December 16, 2024
Physiological response of longfin smelt to changing temperatures and turbiditiesChristina Pasparakis, Felix Biefel, Francine De Castro, et al.
Journal of Clinical Pharmacology|March 1, 1996
Pharmacokinetics of ondansetron in patients with hepatic insufficiencyW D Figg, G E Dukes, J F Pritchard, et al.
Journal of Clinical Pharmacology|July 13, 2013
Concomitant oral and intravenous pharmacokinetics of dabrafenib, a BRAF inhibitor, in patients with BRAF V600 mutation-positive solid tumorsCathrine L Denton, Elisabeth Minthorn, Stanley W Carson, et al.
Pageof 138